WaitesKBTalkingtonDF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728.
2.
SchalockPCDinulosJGHPaceNSchwarzenbergerKWengerJK. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol. 2006;23:546-555.
3.
RavinKARappaportLDZuckerbraunNSWadowskyRMWaldERMichaelsMM. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series. Pediatrics. 2007;119:e1002-e1005.
4.
ZipitisCSThalangeN. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. Eur J Pediatr. 2007;166:585-588.
5.
VanfleterenIVan GyselDDe BrandtC. Stevens-Johnson syndrome: a diagnostic challenge in the absence of skin lesions. Pediatr Dermatol. 2003;20:52-56.
6.
LatschKGirschickHJAbele-HornM. Stevens- Johnson syndrome without skin lesions. J Med Microbiol. 2007;56:1696-1699.
7.
McGouranDCRPettersonTMcLarenJMWolbinskiMP. Mucositis, conjunctivitis but no rash—the “atypical Stevens-Johnson syndrome.”Acute Med. 2011;10:81-82.
8.
BressanSMionTAndreolaBBisognoGDa DaltL. Severe Mycoplasma pneumoniae-associated mucositis treated with immunoglobulins. Acta Paediatr. 2011;100:e238-e240.
9.
FinkelsteinYSoonGSAcunaP. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics. 2011;128:723-728.
10.
TempletonKEScheltingaSAGraffelmanAW. Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J Clin Microbiol. 2003;41:4366-4371.
